Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | Zendy

Philipp Harter | Zendy; Jalid Sehouli | Zendy; Ignace Vergote | Zendy; Gwénaël Ferron | Zendy; Alexander Reuß | Zendy; Werner Meier | Zendy; Stefano Greggi | Zendy; Berit Jul Mosgaard | Zendy; Frédèric Selle | Zendy; Frédéric Guyon | Zendy; Christophe Pomel | Zendy; Fabrice Lécuru | Zendy; Rongyu Zang | Zendy; Elisabeth ÅvallLundqvist | Zendy; JaeWeon Kim | Zendy; Jordi Ponce | Zendy; Francesco Raspagliesi | Zendy; Gunnar B. Kristensen | Zendy; JeanMarc Classe | Zendy; Peter Hillemanns | Zendy; Pernille Tine Jensen | Zendy; Annette Hasenburg | Zendy; Sadaf GhaemMaghami | Zendy; Mansoor Raza Mirza | Zendy; Bente Lund | Zendy; Alexander Reinthaller | Zendy; Ana Santaballa | Zendy; Adeola Olaitan | Zendy; Felix Hilpert | Zendy; Andreas du Bois | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

Author(s) -

Philipp Harter,

Jalid Sehouli,

Ignace Vergote,

Gwénaël Ferron,

Alexander Reuß,

Werner Meier,

Stefano Greggi,

Berit Jul Mosgaard,

Frédèric Selle,

Frédéric Guyon,

Christophe Pomel,

Fabrice Lécuru,

Rongyu Zang,

Elisabeth ÅvallLundqvist,

JaeWeon Kim,

Jordi Ponce,

Francesco Raspagliesi,

Gunnar B. Kristensen,

JeanMarc Classe,

Peter Hillemanns,

Pernille Tine Jensen,

Annette Hasenburg,

Sadaf GhaemMaghami,

Mansoor Raza Mirza,

Bente Lund,

Alexander Reinthaller,

Ana Santaballa,

Adeola Olaitan,

Felix Hilpert,

Andreas du Bois

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2103294

Subject(s) - medicine , hazard ratio , surgery , chemotherapy , cytoreductive surgery , randomized controlled trial , ovarian cancer , confidence interval , randomization , clinical endpoint , cancer

Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research